Prolonged-release aspirin

Flamasacard, a prolonged-release formulation of aspirin, for secondary prophylaxis after a first coronary or cerebrovascular ischaemic event and following coronary angioplasty or coronary artery bypass graft.

A dose of one capsule (162.5mg acetylsalicyclic acid) should be taken at the same time each day 15 minutes before food.

Flamasacard is not suitable in situations where a rapid onset of action is required, such as the acute treatment of myocardial infarction or unstable angina. In these cases immediate-release aspirin should be administered.

View Flamasacard drug record

Further information: Abbey Pharmaceuticals


Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more